Vulvar intraepithelial neoplasia

Results: 34



#Item
1HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GARDASIL 9 safely and effectively. See full prescribing information for GARDASIL 9. ®

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GARDASIL 9 safely and effectively. See full prescribing information for GARDASIL 9. ®

Add to Reading List

Source URL: www.merck.com

Language: English - Date: 2015-03-26 19:23:33
213027_2015_8_Article 1..6

13027_2015_8_Article 1..6

Add to Reading List

Source URL: www.infectagentscancer.com

Language: English
3CHAPTER 6 Tumours of the Vagina Although the incidence rate of vaginal intraepithelial neoplasia is increasing, that of squamous cell carcinoma is decreasing, reflecting earlier detection and more successful treatment.

CHAPTER 6 Tumours of the Vagina Although the incidence rate of vaginal intraepithelial neoplasia is increasing, that of squamous cell carcinoma is decreasing, reflecting earlier detection and more successful treatment.

Add to Reading List

Source URL: www.iarc.fr

Language: English - Date: 2015-02-25 08:39:27
4CHAPTER 7 Tumours of the Vulva Squamous cell carcinoma of the vulva occurs predominantly in the older age group. Although the incidence rate of vulvar intraepithelial neoplasia is increasing, that of squamous cell carcin

CHAPTER 7 Tumours of the Vulva Squamous cell carcinoma of the vulva occurs predominantly in the older age group. Although the incidence rate of vulvar intraepithelial neoplasia is increasing, that of squamous cell carcin

Add to Reading List

Source URL: www.iarc.fr

Language: English - Date: 2015-02-25 08:39:27
526  talking women clinical review

26 talking women clinical review

Add to Reading List

Source URL: jeanhailes.org.au

Language: English - Date: 2014-12-16 08:19:41
626  talking women clinical review

26 talking women clinical review

Add to Reading List

Source URL: jeanhailes.org.au

Language: English - Date: 2014-12-16 08:19:41
7Rx Update Drugs recently approved or pending approval­ EXELON The US Food and Drug Administration (FDA) has given approval to Novartis Pharmaceuticals Corporation (East Hanover, NJ) to market Exelon (rivastigmine tartra

Rx Update Drugs recently approved or pending approval­ EXELON The US Food and Drug Administration (FDA) has given approval to Novartis Pharmaceuticals Corporation (East Hanover, NJ) to market Exelon (rivastigmine tartra

Add to Reading List

Source URL: www.turner-white.com

Language: English
8Clinical Reviewer: Sixun Yang, MD, PhD STN: [removed]Application Type STN CBER Received Date

Clinical Reviewer: Sixun Yang, MD, PhD STN: [removed]Application Type STN CBER Received Date

Add to Reading List

Source URL: www.fda.gov

Language: English
9Statistical Review - GARDASIL 9

Statistical Review - GARDASIL 9

Add to Reading List

Source URL: www.fda.gov

Language: English
10MID-CYCLE MEETING SUMMARY

MID-CYCLE MEETING SUMMARY

Add to Reading List

Source URL: www.fda.gov

Language: English